In light of AxSys Technologies having been named as the successful bidder in NHS Scotland’s national generic clinical system procurement pr…

There are two aspects to clinical systems delivery with the GCS toolset. The first is the on-going development of the toolset product itself, and its implementation within NHSScotland developer teams, or by third parties commissioned by NHSScotland, to enable clinical systems development. The second relates to the development of clinical applications with the toolset, and their subsequent implementation in the clinical environment. The contract is concerned with the first of these – i.e. the delivery, maintenance and continuous development of a robust and forward-looking toolset that keeps pace with technological advances and clinical requirements, and its successful implementation across NHSScotland. However, the usefulness of GCS-built clinical systems in the delivery of patient care will be the most powerful measure of toolset effectiveness, so benefits realisation measures will take both aspects into account. Criteria for measuring benefits realisation will therefore include the ease, flexibility and build-speed facilitated by the toolset during the development process, plus the clinical acceptability and level of usage of resultant systems.
The contract itself includes an enabling framework with AxSys for the development of applications although this is not an exclusive contract.